Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rank in Stocks #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Share Price
$0.2219522
Last synced: 2025-09-11
Market Cap
$1.10B
Change (1 day)
0.04%
Change (1 year)
0.17%
Country
CN
Trade Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS as of September 2024 TTM: $-0.02
According to Hubei Biocause Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is $-0.02. At the end of 2022 the company had a EPS of $0.01 a decrease compared to its 2021 EPS that were of $0.03.
EPS history for Hubei Biocause Pharmaceutical Co., Ltd. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.02 -21.50%
2023 $-0.02 -226.90%
2022 $0.01 -48.76%
2021 $0.03 -19.60%
2020 $0.04 -58.44%
2019 $0.08 115.52%
2018 $0.04 -14.75%
2017 $0.05 -27.29%
2016 $0.06 128.88%
2015 $0.03 185.57%
2014 $0.01 -178.23%
2013 $-0.01 -985.71%
2012 0.00 -111.76%
2011 $-0.01 -471.88%
2010 0.00 -40.74%
2009 $0.01 -292.86%
2008 0.00 -122.58%
2007 $0.01 113.79%
2006 $0.01 625.00%
2005 0.00 33.33%
2004 0.00 -111.54%
2003 $-0.01 -966.67%
2002 0.00 -80.65%
2001 0.00 0.00%
2000 0.00 0.00%
EPS for similar companies or competitors